scispace - formally typeset
Open AccessJournal ArticleDOI

Drug abuse in schizophrenic patients: clinical correlates and reasons for use.

Reads0
Chats0
TLDR
Schizophrenic patients who abuse drugs may represent a subgroup of patients with better prognoses and less severe clinical characteristics of schizophrenia, but their drug abuse may adversely affect global outcome.
Abstract
Objective: This study aimed to 1) determine substance abuse prevalence and preference in a diverse sample ofschizophrenic, schizoaffective, and schizophreniform inpatients, 2) cornpare drug-abusing and non-drug-abusing patients on demographic and clinical variables during the acute and stabilization phases of their hospital course, and 3) obtain data from patients on reasons for drug abuse and on acute state-related changes during periods of intoxication. Method: Eighty-three psychotic inpatients consecutively admitted to a New York City teaching hospital were evaluated. Sixty-eight had schizophrenia, 12 had schizoaffective disorder, and three had schizophreniforrn disorder diagnosed according to the Structured Clinical Interview for DSM-III-R. Each patient received ratings on the Brief Psychiatric Rating Scale, the Global Assessment Scale, and the Scale for the Assessment of Negative Symptoms at admission and at discharge, an evaluation of premorbid adjustment, and an extensive interview on drug and alcohol use. Results: Forty (48%) of the patients received diagnoses of drug or alcohol abuse or dependence. The drug-abusing patients primanly used cannabis (N=26), alcohol (N=2 1), and cocaine (N= I 4) and reported that they abused drugs to get “high, “ to relieve depression, and to relax. They had significantly fewer positive and negative symptoms at discharge, better sexual adjustment and worse school performance during adolescence, and more family histories ofdrug abuse than the non-d rugabusing patients. Conclusions: Schizophrenic patients who abuse drugs may represent a subgroup of patients with better prognoses and less severe clinical characteristics of schizophrenia, but their drug abuse may adversely affect global outcome.

read more

Citations
More filters
Journal ArticleDOI

Comorbid substance abuse and brain morphology in recent-onset psychosis.

TL;DR: In this paper, the authors compared schizophrenia and schizoaffective patients early in the course of the disease with and without comorbid substance abuse disorder (SUD vs. NSUD) with regard to brain morphology.
Journal ArticleDOI

Current cannabis use and tardive dyskinesia

TL;DR: A trend for females and older patients with a longer duration of illness to show elevated scores on the AIMS is indicated, and cannabis use was found to correlate best with the presence of TD, out-ranking other putative factors.
Journal ArticleDOI

Treatment Satisfaction Compared with Outcome in Severe Dual Disorders

TL;DR: In this article, the authors examined patient satisfaction with over-all care and with casemanagement for severely mentally ill dually diagnosed outpatients participating in long-term integrated dual focus treatment and compared these ratings with case manager ratings of patient outcome over a one year period.
Journal ArticleDOI

Reasons for Cannabis Use: Patients with Schizophrenia Versus Matched Healthy Controls

TL;DR: Stable schizophrenia outpatients treated with atypical antipsychotics do not use cannabis in order to reduce side-effects of medication or symptoms of their disorder, rather, they used cannabis to overcome a feeling of social exclusion.
Journal ArticleDOI

Recent cocaine use decreases negative signs in acute schizophrenia: a case study over two consecutive admissions.

TL;DR: In a recent longitudinal study, subjects in the psychiatric emergency service (PES) were assessed within 48 hours of cocaine ingestion and again 3 weeks into inpatient hospitalization, and it was found that cocaine-abusing schizophrenia patients presented with significantly fewer negative signs compared to abstaining schizophrenic patients in the PES.
References
More filters
Journal ArticleDOI

The Brief Psychiatric Rating Scale

TL;DR: The Brief Psychiatric Rating Scale (BRS) as mentioned in this paper was developed to provide a rapid assessment technique particularly suited to the evaluation of patient change, and it is recommended for use where efficiency, speed, and economy are important considerations.
Journal ArticleDOI

The Global Assessment Scale: A procedure for measuring overall severity of psychiatric disturbance.

TL;DR: The relative simplicity, reliability, and validity of the GAS suggests that it would be useful in a wide variety of clinical and research settings.
Journal ArticleDOI

Negative Symptoms in Schizophrenia: Definition and Reliability

TL;DR: The developed Scale for the Assessment of Negative Symptoms has excellent interrater reliability and the five symptom complexes defined by the scale have good internal consistency, which indicates that the conceptual organization of the scale is also cohesive.
Journal ArticleDOI

One-month prevalence of mental disorders in the United States. Based on five Epidemiologic Catchment Area sites.

TL;DR: One-month prevalence results were determined from 18571 persons interviewed in the first-wave community samples of all five sites that constituted the National Institute of Mental Health Epidemilogic Catchment Area Program as mentioned in this paper.
Journal ArticleDOI

Measurement of Premorbid Adjustment in Chronic Schizophrenia

TL;DR: The Premorbid Adjustment Scale has been found to be useful in identifying patients likely to become chronically hospitalized or at high risk for readmission, and may also serve as a possible predictor of patients with brain abnormalities on a computerized tomography scan.
Related Papers (5)